A questionnaire-based survey among Indian dermatologists regarding the management of androgenetic alopecia with a novel formulation containing alcohol-free minoxidil, procapil and finasteride

A survey of 245 Indian dermatologists showed a preference for treating androgenetic alopecia (AGA) with a novel alcohol-free formulation containing minoxidil, procapil, and finasteride. The study highlighted that 51.4% of dermatologists estimated AGA prevalence at 30%-40%, with 49.3% favoring a combination of topical minoxidil and finasteride with oral supplements for men, and 50.6% recommending a 5% minoxidil solution for women. A significant 79.4% believed alcohol-free minoxidil is superior to alcohol-based versions, and 51% found the alcohol-free combination with procapil and finasteride more effective and safer. The formulation was rated 'good' or 'excellent' by 55% and 45% of dermatologists, respectively, and was better tolerated by 62%, with 64% rating patient adherence as 'good'.